Physician profile
Monica Wright
NPI 1205452984
$353.21
in general payments reported to CMS, 2019-2025
11 companies · $83.60 in 2025
The $83.60 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.02 · 2023: $81.49 · 2024: $170 · 2025: $83.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $100.83 | 2024-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $37.53 | 2024-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $35.28 | 2025 | Abilify Asimtufii, Rexulti |
| Neurocrine Biosciences, INC. | $34.88 | 2023 | Ingrezza |
| Janssen Pharmaceuticals, INC | $32.65 | 2023-2024 | Invega Trinza, Invega Sustenna |
| Teva Pharmaceuticals USA, INC. | $23.16 | 2024 | Austedo Xr |
| Almatica Pharma LLC | $22.31 | 2024 | Loreev Xr |
| Uswm, LLC | $18.02 | 2022 | |
| Merck Sharp & Dohme LLC | $17.75 | 2023 | Belsomra |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $16.45 | 2024 | |
| Lundbeck LLC | $14.35 | 2023 | Abilify Maintena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.